-
Article
Open AccessContext-dependent role of trisomy 6 in myelodysplastic neoplasms and acute myeloid leukemia: a multi-omics analysis
-
Article
Open AccessClonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders
Therapy-related myeloid neoplasms (tMN) are complications of cytotoxic therapies. Risk of tMN is high in recipients of autologous hematopoietic stem cell transplantation (aHSCT). Acquisition of genomic mutatio...
-
Article
Open AccessMolecular and clinical analyses of PHF6 mutant myeloid neoplasia provide their pathogenesis and therapeutic targeting
PHF6 mutations (PHF6MT) are identified in various myeloid neoplasms (MN). However, little is known about the precise function and consequences of PHF6 in MN. Here we show three main findings in our comprehensive ...
-
Article
Open AccessAuthor Correction: Molecular patterns identify distinct subclasses of myeloid neoplasia
-
Article
Open AccessGenomics of deletion 7 and 7q in myeloid neoplasm: from pathogenic culprits to potential synthetic lethal therapeutic targets
Complete or partial deletions of chromosome 7 (-7/del7q) belong to the most frequent chromosomal abnormalities in myeloid neoplasm (MN) and are associated with a poor prognosis. The disease biology of -7/del7q...
-
Article
Open AccessNovel scheme for defining the clinical implications of TP53 mutations in myeloid neoplasia
TP53 mutations (TP53MT) occur in diverse genomic configurations. Particularly, biallelic inactivation is associated with poor overall survival in cancer. Lesions affecting only one allele might not be directly le...
-
Article
Open AccessMolecular patterns identify distinct subclasses of myeloid neoplasia
Genomic mutations drive the pathogenesis of myelodysplastic syndromes and acute myeloid leukemia. While morphological and clinical features have dominated the classical criteria for diagnosis and classificatio...
-
Article
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations
-
Article
Open AccessImpact of immediate cryopreservation on the establishment of patient derived xenografts from head and neck cancer patients
Patient-derived xenografts established from human cancers are important tools for investigating novel anti-cancer therapies. Establishing PDXs requires a significant investment and many PDXs may be used infreq...
-
Article
Open AccessDevelopment and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases
Non-small cell lung cancer (NSCLC) brain metastasis cell lines and in vivo models are not widely accessible. Herein we report on a direct-from patient-derived xenograft (PDX) model system of NSCLC brain metast...
-
Article
Open AccessResistance to targeted therapies as a multifactorial, gradual adaptation to inhibitor specific selective pressures
Despite high initial efficacy, targeted therapies eventually fail in advanced cancers, as tumors develop resistance and relapse. In contrast to the substantial body of research on the molecular mechanisms of r...